Ophthalmology Times: September/October 2025

Deborah A. Ferrington, PhD, highlights how breakthroughs in imaging, AI, and stem cell research are reshaping ophthalmology.

Emerging anti-VEGF agents offer enhanced durability and anatomic outcomes in retinal disease.

Automated standardized graphs facilitate refractive surgery outcome analysis.

Faster cutting speeds and ergonomic design streamline workflows and enhance comfort.

Cases show improved clarity, astigmatism masking, and versatility in complex eyes.

Earlier use of SLT, sustained-release drug delivery, and MIGS is reframing glaucoma care.

Roundtable discussion explores surgical and sustained-release options.

Innovations in surgery, biologics, and AI are shaping the future of eye aesthetics.

How pupil modulation and pharmacologic targeting shape near vision outcomes.

Punctal occlusion may reduce reactions without worsening symptoms

Telemedicine, mobile clinics, and policy reform offer a road map to equitable care.

As ophthalmic technologies move at supersonic speed, AI and gene therapy take center stage.

Explore groundbreaking advancements in eye care from the 2000s, including LASIK innovations, anti-VEGF treatments, and enhanced imaging technologies.

Explore the groundbreaking advancements in ophthalmic technology from the 1980s and 1990s, including excimer lasers, LASIK, and innovative imaging techniques.

From lasers to lenses, the 1970s redefined vision care through breakthroughs in surgery, imaging, and therapeutics.

Emerging pharmacological and optical strategies are shaping a new era.

Maximizing treatment based on GA location, lesion progression, and morphologic retinal changes.

Real-world insights emphasize identifying underlying causes to tailor treatment.

A stepwise guide to optimize astigmatism management in cataract surgery